Car T-Cell Therapy

In this webinar: A novel cancer treatment that engineers our own immune cells to kill cancer. Dr. Jim Whitlock explains Chimeric Antigen Receptor T-cell (CAR-T) therapy, and the emerging challenges and concerns related to its use within the scope of Childhood Acute Lymphoblastic Leukemia. The webinar was followed by an interactive question and answer session.

Effective Advocacy Strategies

The slides for this webinar are available on our Slideshare account.  CCSN welcomed back Ryan Clarke of Advocacy Solutions for an in-depth webinar on best advocacy practices. Topics covered include types of advocacy, the essence and cornerstones of effectiveness and how to develop an impactful plan to get your message across. The webinar was followed by

Radical Remissions: What we can learn from remarkable cancer survivors about living

Broadcasted on Thursday, April 19th, 2018 1:00pm – 2:00pm ET About the Webinar: Oncologist Dr. Rob Rutledge reviewed the book Radical Remissions: Surviving cancer against all odds by Kelly Turner, PhD, and the nine key attitudes and behaviours found in people who have undergone a spontaneous remission. Though not promising a cure, Dr. Rutledge shows

Improving Access to Innovative Cancer Therapies in Canada

The slides for this webinar are available on our Slideshare account.  Robin Markowitz and Elizabeth Lye from Lymphoma Canada discussed recent pCODR drug funding requests for innovative cancer therapies and how negative funding recommendations are affecting patient access to effective new treatments. The presentation was followed by an interactive question and answer session. Originally broadcast on

Bringing Rare Disease Drugs to Canada: Opportunities, Challenges, and More Challenges

About the Webinar: The slides for this webinar are available on our Slideshare account.  This webinar was an interactive live webcast from the Canadian Organization for Rare Disorders’ Rare Disease Day event in Ottawa. The session was moderated by 3Sixty Public Affairs’ Bill Dempster, who was joined by several Canadian experts in pharmaceutical access, including a

CCSN FREE WEBINAR: Anal & Colorectal Cancer with Helene Hutchings

The slides for this webinar can be viewed at our Slideshare account.  Speaker: Helene Hutchings, Founder/CEO of Anal Cancer: A Bum Rap, a Canadian based support group for past/present anal cancer patients and their families Broadcast Date: Thursday, March 8th CCSN welcomes back Helene Hutchings to discuss anal and colorectal cancer in this educational webinar. Helene discussed the

The importance of clinician engagement in the HTA process

About the Webinar: The slides for this webinar can be viewed at our Slideshare account.  Join Alexandra Chambers & oncologist Dr. Craig Earle with CADTH’s pan-Canadian Oncology Drug Review (pCODR) as they discuss the opportunities for clinicians to participate in the process and be part of the system, and how clinician input can help to inform

Federal pharmaceutical pricing reform: What do patients think?

About the Webinar: The slides for this webinar can be viewed at our Slideshare account.  Bill Dempster & guests Louise Binder & Martine Elias discussed the updates to the federal pharmaceutical price reform proposal, how patient leaders are responding and what steps they are taking to ensure that patients are being heard by decision makers. About the

Navigating Private Insurance in Canada

For this webinar, we’re joined by Suzanne Lepage, private health plan specialist, for a discussion of Canada’s private drug plan marketplace and its overlap with government provided services. She’ll walk us through what to expect in terms of coverage and answer audience questions about private insurance.

Clinical Trials 101

This webinar tells you what you need to know about clinical trials, their history, and helps you prepare for a trial. If you’re currently considering participating in a clinical trial, we hope that this webinar answers many of your questions. In the presentation the audience learned the difference between different types of clinical trial and the design and